The main new study presented at the United European Gastroenterology (UEG) week 2025 shows that both sweet sugar (SSB) (SSB) and low or non -function drinks (LNSSB) are significantly associated with an increased risk of metabolic dysfunctional liver disease).
The research was followed by 123,788 biobank participants in the UK without an existing liver disease using a repeated 24 -hour diet questionnaires to assess the consumption of drinks. The study was monitored by the development of Masld, accumulation of liver fats and mortality -related mortality in the median 10.3 years of monitoring.
Increased risk found for both types of drinks
It has been found that participants consuming more than 250 g per day LNSSB or SSB have a higher risk of MASLD development 60% (HR: 1.599) and 50% (HR: 1.469). Among the cohorts, 1,178 participants developed Masld and 108 died of the causes of jathers. While the SSB was not associated with the mortality -related mortality, LNSSB consumption was associated with higher -related deaths. Both types of drinks were also associated with an increased liver fat content.
MASLD: Growing global concern
Masld, formerly known as non -alcoholic greasy liver disease (NAFLD), occurs when fat accumulates in the liver, which potentially leads to inflammation and symptoms such as pain, fatigue and loss of appetite. This situation affects more than 30% of people around the world and is a rapidly growing cause of death related to yat.
Expertise
The head of Lihe Liu, a postgraduate student at the Department of Gastroenterology, the first associated hospital at Sochow University, said, “SSB has not been under control for a long time, while their” diet “alternatives are often considered a healthier choice. However, both are widely consumed and their effects on liver health have not been well understood. ”
Liu added: “Our study shows that LNSSB was actually associated with a higher Masld risk, even at mild intake levels, such as the only can a day. These findings question the common perception that these drinks are harmless and emphasize the need to reconsider their role and liver health.”
Prevention by selecting drinks
The study emphasizes the limitation of both SSB and LNSSB within a wider strategy to prevent liver and metabolic disease. Replacing these beverages significantly reduced the risk of Masld – 12.8% for SSB and 15.2% for LNSSB – while switching between the two types of drinks did not offer any risk reduction.
Liu concluded: “The safest approach is to reduce both sugar and artificially coordinated drinks. The water remains the best choice because it removes metabolic load and prevents fat accumulation in the liver while moisturizing the body.”
(Tagstotranslate) Sugar-Sweened Beverages (T) Low-Or Non-Sugar-Sweened Beveration (T) Metabolic Dysfunction-Assocated Steatotic Liver Disease (T) Liver Fat Accumulation (T) Liver-Related Mortality Beverages SSBS (T) Low-Or Non-Sugar-Sweened Beverages LNSSBS (T) Metabolic Non-Alcoholic Hatter Disease (T) Artificial Drinks (T) liver disease (T) for sugar beverages
